Skip to content

Notalvision

Request correction

A digital health company providing remote patient monitoring services for retinal diseases.

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Notal Vision is a digital health company that extends eye disease management from the clinic to the home, using AI-enabled data analysis. It offers remote monitoring services and home-based diagnostic devices for retinal diseases.

History

Notal Vision has its roots in Tel Aviv, Israel. The company developed ForeseeHome, a daily at-home test for Age-related Macular Degeneration (AMD). A large randomized clinical trial (AREDS2 HOME Study) conducted by the US National Eye Institute followed 1,520 dry AMD patients and demonstrated the vision benefit of ForeseeHome. Notal Vision launched the product and gained US Medicare reimbursement in late 2015. Today, headquarters is located in Manassas, Virginia, with R&D in Tel Aviv, led by CEO Kester Nahen, PhD.

Products and positioning

  • ForeseeHome

  • SCANLY Home OCT

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/notalvision · Editorial policy · How profiles are compiled